• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

September 23, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Errata- FDA Briefing Document for BH110018

Errata- FDA Briefing Document for BH110018, September 23, 2011

  1. Page 16, first bullet, third sentence: delete text “or Propidium Iodide”.
  2. Page 16, second bullet, change the text to read “Determination of lymphocyte content including T-cells, B-cells, and NK-cells of allogeneic donor products using CD3, CD4, CD8, CD19, CD56, and CD14 expression as detected by flow cytometry.”